https://www.selleckchem.com/pr....oducts/cd38-inhibito
There were 58 cases of recurrence out of 368 patients over a median length of follow-up of 18 months (interquartile range 12-34months). The total weighted overall recurrence was 12%. There were 51 cases of postoperative complications in 350 cases, bleeding being the most common complication. The recurrence rate is comparable to those of the well-established Altemeier and Delorme procedures. However, given the heterogeneity of studies and variations in lengths of follow-up, further randomized prospective studies are needed to ad
إعجاب
علق
شارك
